Financial results: Full year 2025 earnings of $0.00 per share (-$0.25 per share in 2024). The Company ended the year with total assets of $108.9 million, including $5.7 million in cash and cash ...
I once watched a board chair yawn at my slide. It was quiet and polite, like a man stuck in an elevator with bad music. The ...
Good afternoon, and thank you all for joining us today to discuss Assertio Holdings, Inc.'s fourth quarter 2025 financial results and business update. Please note that during this call, management ...
Relocating a retail store in Atlanta can unlock better foot traffic, lower occupancy costs, and a stronger brand presence. It can also disrupt sales, strain staff, and damage inventory if […] ...
Posting fourth consecutive quarter of growth and highest recorded annual revenue in the Company’s history - - Lowest Quarterly Net Loss since 2013 – Evidencing further progress toward profitability - ...
A Breakthrough Integration of Non-Financial Tokenization and the Real-World Goods Economy "Directly Addressing the Retail Gap ...
Precigen transitioned to a commercial stage company with the US approval of PAPZIMEOS(TM) (zopapogene imadenovec-drba), the first-and-only FDA-approved treatment for adults with RRP, in August 2025 -- ...
And we are excited to welcome all colleagues from the entire Restaurant Depot team to the Sysco family. Starting on Slides 5 and 6. On today's call, we'll provide an overview of the transaction, ...
Sources close to Netflix reveal the streamer's partnership with Meghan Markle and Prince Harry has been fraught -- and it ...
Q4 2025 Earnings Call March 19, 2026 8:00 AM EDTCompany ParticipantsJin Li - Head of Investor RelationsLong Chen - Founder, ...
YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here's the roundup for Wednesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results